# Editorial: Exploring sulfur compounds’ role in inflammation and therapeutic potential

**Authors:** Małgorzata Iciek, Tomohiro Sawa, Eugenia Rita Lauriano, Magdalena Kotańska

PMC · DOI: 10.3389/fimmu.2026.1804564 · Frontiers in Immunology · 2026-02-12

## Full-text entities

- **Diseases:** sepsis (MESH:D018805), bacterial infection (MESH:D001424), RSS (MESH:D000275), COVID-19 (MESH:D000086382), rheumatoid arthritis (MESH:D001172), MAFLD (MESH:D005234), autoimmune diseases (MESH:D001327), influenza (MESH:D007251), inflammation (MESH:D007249)
- **Chemicals:** SO2 (MESH:D013458), cysteine (MESH:D003545), persulfides (MESH:C051552), leukotriene (MESH:D015289), LTB4 (MESH:D007975), disulfide (MESH:D004220), ROS (-), H2S (MESH:D006862), Sulfur (MESH:D013455), sulfur compounds (MESH:D013457), polysulfides (MESH:C032915)
- **Species:** Salmonella enterica subsp. enterica serovar Typhimurium (no rank) [taxon 90371]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12935607/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12935607/full.md

---
Source: https://tomesphere.com/paper/PMC12935607